Selection of Chemotherapy in Advanced Poorly Differentiated Extra-Pulmonary Neuroendocrine Carcinoma

SIMPLE SUMMARY: Extra-pulmonary poorly differentiated neuroendocrine carcinoma is a rare tumour type with a limited evidence base for its treatment. Recent work has helped to clarify the optimum first-line chemotherapy regimen. However, in the second-line setting, data remain sparse. A more personal...

Descripción completa

Detalles Bibliográficos
Autores principales: Weaver, Jamie M. J., Hubner, Richard A., Valle, Juan W., McNamara, Mairead G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604995/
https://www.ncbi.nlm.nih.gov/pubmed/37894318
http://dx.doi.org/10.3390/cancers15204951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604995/
https://www.ncbi.nlm.nih.gov/pubmed/37894318
http://dx.doi.org/10.3390/cancers15204951

Ejemplares similares